Big Health Business Unit

Being located in the Research Triangle Park of North Carolina US, Avioq Inc. focuses on the development of antigen/antibody-based (immune) diagnosis/confirmation technology and reagents. The company’s research team participated in developing the first batch of HIV assays approved by FDA and the first HIV antigen test kit in the world, as well as the R&D and production for the first batch of HBV assays.

Main self-developed products of Avioq include: FDA-approved HTLV-I/II Microelisa System, VioOneTM HIV ProfileTM Supplemental Assay and HIV-1 Microelisa System etc. Furthermore the company has accumulated more than 80 EU approvals, and become an international leader in the field of immune diagnostic reagents development.

Add：76 T.W. Alexander Drive Research Triangle Park North Carolina, 27709 United States

Tel: 1.919.314.5535 E-mail: customerservice@avioq.com